Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **hypoglossal nerve** is the twelfth cranial nerve (CN XII) and is responsible for motor innervation to all intrinsic and most extrinsic muscles of the tongue (except the palatoglossus muscle, which is innervated by the vagus nerve). It originates from the hypoglossal nucleus in the medulla oblongata of the brainstem. The hypoglossal nerve exits through the hypoglossal canal at the base of the skull and travels to supply muscles that control movements essential for speech, swallowing, chewing, and clearing saliva. Damage to this nerve can lead to weakness or paralysis of tongue muscles on one or both sides, resulting in difficulties with articulation and swallowing[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoglossal nerve (CN XII).